-
Pharmacological exposure to ribavirin: a key player in the complex network of...
International audience -
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI2013...
International audience -
Treatment of recurrent HCV infection following liver transplantation: results...
International audience -
The treatment response of chronically hepatitis C virus-infected patients dep...
International audience -
Factors that predict response of patients with hepatitis C virus infection to...
International audience -
Sustained virological response after 14-day treatment with danoprevir and 48-...
International audience -
Boceprevir for untreated chronic HCV genotype 1 infection.
International audience -
Effectiveness of chronic hepatitis C treatment in drug users in routine clini...
International audience -
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in...
International audience -
Mutational robustness of an RNA virus influences sensitivity to lethal mutage...
International audience
